deltatrials

Radiotherapy Trials in Beijing, China

Conditions / Radiotherapy / Beijing, China

Research into Radiotherapy spans multiple therapeutic approaches and trial phases.

27 total trials for this combination

Showing top 10 of 27 trials

Trials

NCT ID Title Status Phase
NCT06202014 Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC UNKNOWN PHASE2
NCT06233981 Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis COMPLETED
NCT06433817 Spectral CT in Radiotherapy for Cervical Cancer RECRUITING
NCT04791176 Phase II Study of Concurrent Lenvatinib and Radiotherapy for Advanced HCC COMPLETED PHASE2
NCT03963726 Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer. UNKNOWN NA
NCT06205472 Phase II Study of Adjuvant SIB Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC. RECRUITING PHASE2
NCT06389422 Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis RECRUITING PHASE2
NCT05802641 Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer UNKNOWN
NCT07058948 Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors RECRUITING
NCT06353061 Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer RECRUITING PHASE2

Related Pages